Table 1.
Aberrant miRNAs in ALS.
MiRNA | Model | Function and Changes | Ref | |
---|---|---|---|---|
Animal model | miRNA-125b![]() |
SOD1-G93A mouse | Increase of TNFα transcription by interfering with the STAT3 pathway | [44] |
miRNA-124![]() |
Aberrant modulation of astrocytic differentiation by targeting Sox2 and Sox9 | [45] | ||
miRNA-128![]() |
Aberrant modulation of the excitatory amino acid transporter 2 | [46] | ||
miRNA-193b-3p![]() |
Stimulation of cell death by targeting tuberous sclerosis 1 (TSC1) | [47] | ||
miRNA-375-3p![]() |
Wobbler mouse | Inefficient inhibition of p53, increasing ROS production, and induction of cell death | [48] | |
ALS patients | miRNA-146*![]() |
sALS | Interaction with NFL mRNA, and suppression of its expression | [49] |
miRNA-524-5p![]() miRNA-582-3p ![]() |
sALS | Aberrant regulation of NFL mRNA 3′UTR | [49] | |
miRNA-375![]() |
FUS mutant ALS | Aberrant targeting of the apoptotic factor ELAV-like protein 4 | [50] | |
miRNA-494-3p![]() |
C9orf72 mutant ALS | Aberrant regulation of semaphorin 3A | [51] | |
miRNA-223-3p![]() miRNA-338-39 ![]() miRNA-326 ![]() |
sALS | Altered homeostasis in the neuromuscular junction | [52] | |
miRNA-1![]() miRNA-19a-3p ![]() miRNA-133a-3p ![]() miRNA-133b ![]() miRNA-144-5p ![]() miRNA-192-3p ![]() miRNA-192-5p ![]() |
fALS and sALS | Altered homeostasis in the serum | [53] | |
Let-7d3p![]() miRNA-139-5p ![]() miRNA-320a ![]() miRNA-320c ![]() miRNA-320b ![]() miRNA-425-5p ![]() |
sALS and fALS | Altered homeostasis in the serum | [53] | |
miRNA-1825![]() |
sALS and fALS | Overtranslation of tubulin-folding cofactor b, which contributes to the degradation of tubulin alpha-4A | [54] | |
miRNA-424![]() miRNA-206 ![]() |
ALS | Altered homeostasis in the plasma and in the skeletal muscle | [55] | |
miRNA-338-3p![]() |
sALS | Altered homeostasis in leukocytes | [56] | |
miRNA-206![]() |
sALS | Altered homeostasis in the serum (no significant change in the serum over time) | [57] | |
miRNA-143-3p![]() miRNA-374b-5p ![]() |
sALS | Altered homeostasis in the serum (significant change in the serum over time) | [57] | |
miRNA-181a-5p![]() miRNA-21-5p ![]() ![]() |
ALS | Alteration of apoptotic mechanism inhibition and cell proliferation | [40] |